Skip to main content

MAIA Biotechnology, Inc.

MAIA
Exchange
NYSE
Industry
Pharmaceutical Preparations
SEC CIK
0001878313

In the last 90 days, MAIA Biotechnology, Inc. insiders filed 5 open-market purchases and 0 sales; 36 institutions reported holding it in 13F filings for Q2 2026, worth $19.4M in total; no superinvestor holds it.

Superinvestors holding MAIA, Q2 2026

See all superinvestors

No superinvestor reported holding MAIA in Q2 2026.